Alexandre Gaymard
Alexandre Gaymard
Affiliation inconnue
Adresse e-mail validée de
Citée par
Citée par
Clinical and virological data of the first cases of COVID-19 in Europe: a case series
FX Lescure, L Bouadma, D Nguyen, M Parisey, PH Wicky, S Behillil, ...
The Lancet Infectious Diseases 20 (6), 697-706, 2020
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
G Spiteri, J Fielding, M Diercke, C Campese, V Enouf, A Gaymard, A Bella, ...
Eurosurveillance 25 (9), 2000178, 2020
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled …
F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ...
The Lancet Infectious Diseases 22 (2), 209-221, 2022
Cluster of coronavirus disease 2019 (COVID-19) in the French Alps, February 2020
K Danis, O Epaulard, T Bénet, A Gaymard, S Campoy, E Botelho-Nevers, ...
Clinical Infectious Diseases 71 (15), 825-832, 2020
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
Type I IFN immunoprofiling in COVID-19 patients
S Trouillet-Assant, S Viel, A Gaymard, S Pons, JC Richard, M Perret, ...
Journal of Allergy and Clinical Immunology 146 (1), 206-208. e2, 2020
Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020
A Bal, G Destras, A Gaymard, K Stefic, J Marlet, S Eymieux, H Regue, ...
Eurosurveillance 26 (3), 2100008, 2021
Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia
A Pizzorno, B Padey, T Julien, S Trouillet-Assant, A Traversier, ...
Cell Reports Medicine 1 (4), 2020
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort
N Néant, G Lingas, Q Le Hingrat, J Ghosn, I Engelmann, Q Lepiller, ...
Proceedings of the National Academy of Sciences 118 (8), e2017962118, 2021
Functional balance between Neuraminidase and Hemagglutinin in influenza viruses
A Gaymard, N Le Briand, E Frobert, B Lina, V Escuret
Clinical Microbiology and Infection, 2016
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ...
Proceedings of the National Academy of Sciences 119 (21), 2022
Performance Assessment of SARS-CoV-2 PCR Assays Developed by WHO Referral Laboratories
S Etievant, A Bal, V Escuret, K Brengel-Pesce, M Bouscambert, V Cheynet, ...
Journal of Clinical Medicine 9 (6), 1871, 2020
Impact of original, B. 1.1. 7, and B. 1.351/P. 1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control …
T Charmet, L Schaeffer, R Grant, S Galmiche, O Chény, C Von Platen, ...
The Lancet Regional Health–Europe 8, 2021
Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France
JS Casalegno, D Ploin, A Cantais, E Masson, E Bard, M Valette, R Fanget, ...
Eurosurveillance 26 (29), 2100630, 2021
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Infection 49 (5), 889-905, 2021
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y. V1 (B. 1.1. 7, variant of concern 202012/01) in France, January to March 2021
A Gaymard, P Bosetti, A Feri, G Destras, V Enouf, A Andronico, S Burrel, ...
Eurosurveillance 26 (9), 2100133, 2021
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del)
A Bal, G Destras, A Gaymard, M Bouscambert-Duchamp, M Valette, ...
Clinical Microbiology and Infection 26 (7), 960-962, 2020
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
Q Le Hingrat, B Visseaux, C Laouenan, S Tubiana, L Bouadma, ...
Clinical Microbiology and Infection 27 (5), 789. e1-789. e5, 2021
SARS-CoV-2 Omicron variant, lineage BA. 1, is associated with lower viral load in nasopharyngeal samples compared to Delta variant
C Sentis, G Billaud, A Bal, E Frobert, M Bouscambert, G Destras, L Josset, ...
Viruses 14 (5), 919, 2022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20